Litigation Details for Bayer Intellectual Property GmbH v. Sigmapharm Laboratories, LLC (D. Del. 2017)
✉ Email this page to a colleague
Bayer Intellectual Property GmbH v. Sigmapharm Laboratories, LLC (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-05-26 |
Court | District Court, D. Delaware | Date Terminated | 2020-12-22 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,157,456; 9,539,218 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Bayer Intellectual Property GmbH v. Sigmapharm Laboratories, LLC
Details for Bayer Intellectual Property GmbH v. Sigmapharm Laboratories, LLC (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-06-28 | 11 | obviousness-type double patenting over claims 13, 24 and 30 of U.S. Patent No. 7,157,456 (“the ’456 patent”) and over… infringement of U.S. Patent No. 9,539,218 (“the ’218 patent”) under the Patent Laws of the United States…claims in a later patent that are not patentably distinct from claims in an earlier patent. See, Eli Lilly…double patenting rejection of claims 1, 4, 5, 11 and 18 of the ’218 patent over the ’456 patent in view…Complaint purports to assert claims of patent infringement under the Patent Laws of the United | External link to document | |
2020-12-29 | 34 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (Attachments: #… 22 December 2020 1:17-cv-00648 830 Patent None District Court, D. Delaware | External link to document |
2017-05-26 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (ceg) (Entered:…2017 24 August 2018 1:17-cv-00648 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |